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Abstract
The Clp ATPases (Hsp100) constitute a family of closely related proteins that have protein reactivating and remodelling
activities typical of molecular chaperones. In Staphylococcus aureus the ClpX chaperone is essential for virulence and for
transcription of spa encoding Protein A. The present study was undertaken to elucidate the mechanism by which ClpX
stimulates expression of Protein A. For this purpose, we prepared antibodies directed against Rot, an activator of spa
transcription, and demonstrated that cells devoid of ClpX contain three-fold less Rot than wild-type cells. By varying Rot
expression from an inducible promoter we showed that expression of Protein A requires a threshold level of Rot. In the
absence of ClpX the Rot content is reduced below this threshold level, hence, explaining the substantially reduced Protein A
expression in the clpX mutant. Experiments addressed at pinpointing the role of ClpX in Rot synthesis revealed that ClpX is
required for translation of Rot. Interestingly, translation of the spa mRNA was, like the rot mRNA, enhanced by ClpX. These
data demonstrate that ClpX performs dual roles in regulating Protein A expression, as ClpX stimulates transcription of spa
by enhancing translation of Rot, and that ClpX additionally is required for full translation of the spa mRNA. The current
findings emphasize that ClpX has a central role in fine-tuning virulence regulation in S. aureus.
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Introduction
Staphylococcus aureus is an opportunistic pathogen capable of
causing a variety of diseases in humans, ranging from localized
infections of skin and soft tissue to life-threatening systemic
infections [1]. The pathogenicity of S. aureus relies on a wide array
of surface-bound and secreted virulence factors that provide the
bacterium with the ability of tissue binding, tissue destruction, and
immune evasion [2]. These virulence factors are coordinately
produced in a growth phase dependent manner. The cell-surface
associated factors are primarily expressed during exponential
growth phase, whereas expression of the secreted factors is induced
upon transition to stationary phase. Central for this regulation is
the quorum sensing agr locus [3].
Protein A is a major surface bound virulence factor found in all
examined strains of S. aureus [4]. It is well-known for its ability to
bind the Fc-region of IgG from several mammalian species [5].
Additionally, Protein A can bind von Willebrand factor, and is
capable of inducing inflammatory responses in the host [5,6].
Accordingly, the importance of Protein A in infections has been
demonstrated in several animal models [7–9].
Expression of Protein A is regulated by growth phase and is
controlled by complex regulatory networks acting at both the
transcriptional, translational and post-translational levels [10–13].
The complex regulation of Protein A expression has been
schematically depicted in Fig. 1. At the pinnacle of this regulatory
network is the Agr quorum sensing system reviewed in [14]. The
effector molecule of the agr quorum sensing system is RNAIII, a
small regulatory RNA that is strongly induced in the post-
exponential growth phase [14]. RNAIII is 514 nucleotides long
and folds into a complex secondary structure comprising 14 distinct
stem-loops [15]. Recent evidence supports that RNAIII fulfils its
role as a global virulence regulator primarily by controlling
translation of target genes [12,16–18]. In regard to Protein A
expression, RNAIII acts both directly and indirectly to reduce
synthesis of the protein. Directly, RNAIII down regulates expression
of Protein A by binding to the spa mRNA [12]. This binding reduces
Protein A synthesis at two levels, as it both inhibits translation and
promotes degradation of the spa mRNA [12]. Indirectly, RNAIII
reduces transcription of spa by inhibiting translation of Rot [17]. As
illustrated in Fig. 1, Rot activates spa transcription directly by
binding to the spa promoter, and additionally, by enhancing
transcription of sarS, encoded directly upstream of spa [11,13].
Similar to Rot, SarS activates spa transcription through direct
interactions with the spa promoter region [10,11,13,19]. The
activator activities of Rot and SarS are counteracted by the
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12752
repressor SarA [10,13]. Present models suggest that SarS and Rot
act synergistically to promote spa transcription, whereas the
repressor SarA and the activator SarS compete for overlapping
binding sites in the spa promoter [10,11,13].
We recently revealed an additional layer of regulation by
showing that the levels of spa transcript and Protein A were
severely reduced in mutants lacking ClpX [20,21]. Notably, we
additionally showed that the clpX gene is essential for virulence of
S. aureus [21]. The ClpX protein belongs to the family of closely
related Clp ATPases that function as molecular chaperones
[22,23]. Additionally, ClpX can interact with the unrelated ClpP
peptidase forming a proteolytic complex [24–26]. In the ClpXP
protease, ClpX serves to specifically recognize and subsequently
unfold and translocate the substrate into the ClpP proteolytic
chamber for degradation [24,26–28]. Interestingly, we found that
Protein A expression was un-affected by the absence of ClpP
[20,21]. We therefore hypothesized that it is the ClpP independent
chaperone activity of ClpX that is required for synthesis of Protein
A. Further genetic analyses indicated that ClpX stimulates spa
transcription by controlling either activity or synthesis of the
transcriptional regulator Rot (Fig. 1) [20,21]. The present study
was undertaken to elucidate the molecular mechanism by which
ClpX regulates Protein A expression. Here, we report that
expression of Protein A requires a threshold level of Rot. In the
absence of ClpX, the Rot content is below this threshold level
resulting in lack of Protein A expression. An important finding is
that ClpX enhances expression of Rot at the level of translation,
and that ClpX additionally enhances translation of the spa mRNA.
Hence, ClpX performs dual roles in regulating Protein A
expression, as ClpX stimulates transcription of spa indirectly by
enhancing translation of Rot and additionally enhances translation
of the spa mRNA.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids are listed in Table 1. S. aureus
8325-4 and SA564 were used as wild-type strains. As primary
recipient for plasmids the restriction deficient strain S. aureus
RN4220 [29,30] was used. S. aureus strains were grown in
Tryptic Soya Broth media (TSB; Oxoid) under vigorous
agitation (200 rpm) at 37uC. Usually 20 ml of medium was
inoculated in 200 ml flasks to allow efficient aeration of the
medium. For solid medium, 1.5% agar was added to give TSA
plates. Erythromycin (5 mg ml21), chloramphenicol (5 mg ml21),
or tetracycline (5 mg ml21) was added as required. Upon receipt
of the low-passage isolate SA564 (from G. Somerville) the strain
was cultured once and stored frozen at 280uC. In all
experiments we used SA564 streaked freshly from this stock.
Escherichia coli strains Top10, Top10F’ or StrataClone Solopack
Competent Cells were used for DNA cloning and were grown in
Luria–Bertani (LB; Oxoid) broth or on LB agar plates at 37uC.
Tetracycline (10 mg ml21), kanamycin (50 mg ml21), chloram-
phenicol (35 mg ml21) or ampicillin (50 mg ml21) was added as
required.
Plasmid and strain construction
SA564DclpX. For construction of SA564DclpX, pSaDclpX
from RN4220 [21] was electroporated into competent SA564 cells
at 30uC as described in [31]. A strain containing a 655 bp in frame
deletion in the clpX gene was obtained by allelic replacement as
described in [21], except that the final plasmid-loss was performed
at 37uC. Verification of the chromosomal clpX deletion was done
as described in [21].
Restoration of the chromosomal clpX locus in 8325-
4DclpX and SA564 DclpX
As we were unable to clone an error-less clpX gene in E. coli an
alternative strategy was employed to complement the clpX deletion
in 8325-4 and SA564:
In the course of attempting to create a clpX deletion in the
strain Newman following the same procedure as described in
the present manuscript and in [21], we obtained the desired
chromosomal deletion of clpX (D. Frees, unpublished data).
However, following replacement recombination these colonies
Figure 1. Model depicting the regulatory network controlling Protein A expression. Transcription of spa is positively regulated by the
transcriptional activators Rot and SarS and negatively regulated by SarA [10,11,13,41]. Translation of spa and rot mRNAs is inhibited by RNAIII [12]. We
hypothesized that ClpX stimulates Protein A expression by stimulating either synthesis or activity of Rot (indicated by the dotted arrow). See text for
further details. Solid arrows indicate activation, while solid T-bars indicate repression. Proteins are indicated by spheres. mRNAs are indicated by wavy
lines. Promoters are indicated by bent arrows.
doi:10.1371/journal.pone.0012752.g001
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still maintained a plasmid-borne copy of the intact clpX gene (and
its promoter). This plasmid was transformed into SA564 and
8325-4, and used to restore the chromosomal clpX locus by doing
the same double cross-over procedure as initially used to create
the clpX deletion [21]. Colonies containing an intact chromo-
somal copy of the clpX gene were identified by colony PCR using
the primers SaclpX385f (59-GACGATGCAGAACAACGTG)
and SaclpX2447r (59-CCATACCCTGGAACATCCAC), and
subsequently plasmid loss was achieved by growing at the non-
permissive temperature.
Table 1. Bacterial strains and plasmids used.
S. aureus strains Relevant genotype Reference
8325-4 Reference strain [29]
RN4220 Restriction-deficient mutant of 8325-4 [30]
RN6911 8325-4, agr::tetM (TetR) [46]
HI2209 8325-4:: DclpX [21]
WA525 8325-4, rot::erm [11]
HI2433 8325-4, rot::TN917 [47]
DF2269 8325-4:: DclpX, agr::tetM (TetR) [20]
LJ93 8325-4/pLOJ132, (ErmR) This work.
LJ97 agr/pLOJ132, (ErmR) (TetR) This work.
LJ94 DclpX/pLOJ132, (ErmR) This work.
LJ135 DclpX; agr/pLOJ132, (ErmR) (TetR) This work.
LJ98 8325-4/pLOJ133, (ErmR) This work.
LJ102 agr/pLOJ133, (ErmR) (TetR) This work.
LJ99 DclpX/pLOJ133, (ErmR) This work.
LJ133 DclpX; agr/pLOJ133, (ErmR) (TetR) This work.
LJ113 8325-4/pLUG520, (ErmR) [12]
LJ117 agr/pLUG520, (ErmR) (TetR) [12]
LJ115 DclpX/pLUG520, (ErmR) This work.
LJ121 DclpX; agr/pLUG520, (ErmR) (TetR) This work.
HI2438 8325-4, hfq mutant (CamR) This work.
LJ118 WA525/pWA163. This work.
SA564 Clinical isolate [37]
HI2781 SA564:: DclpX This work.
HI2870 8325-4:: DclpX+clpX This work.
HI2871 SA564:: DclpX+clpX This work.
E. coli strains
Top10 Cloning strain Invitrogen
Top10F’ Cloning strain Invitrogen
ER2566 Protein expression strain NEB
Strataclone cells Cloning strain Stratagene
Plasmids
pET28a+ His-tag vector (KanR) Novagen
pET100/D His-tag vector (AmpR) Invitrogen
pRMC2 shuttle-vector with tet-inducible promoter (CamR) [32]
pLOJ104 pET28a+ derivative with rot -his6, (Kan
R) This work.
pET100clpX pET100/D-derivative with clpX-his6, (Amp
R) This work
pLUG520 PrpoB:spa lacZ translational fusion, (ErmR) [12]
pLOJ132 PrpoB::rot lacZ translational fusion, (ErmR) This work
pLOJ133 PrpoB:: lacZ transcriptional fusion, (ErmR) This work
pUC19 E. coli cloning vector (AmpR) This work
pLOJ131 PrpoB:rot lacZ fusion in pUC19 (AmpR) This work
pWA163 PxylA:rot (TetR) [11]
pASrot PtetO::rot (anti-sense) (CamR) This work
doi:10.1371/journal.pone.0012752.t001
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Construction of pASrot expressing anti-sense rot from an
inducible promoter
To vary the Rot content in SA564 we used the expression vector
pRMC2 [32]. This plasmid harbors an improved copy of the tetO
promoter in pALC2073 that ensures complete repression when
non-induced and high expression when induced by anhydrote-
tracycline. The rot gene was PCR-amplified from 8325-4
chromosomal DNA using the primers KpnI-rotF (59-TTAC-
CATGGTACC ATTGGGAGATGTTTAGCATG) and SacI-
rotR (59-ACATCAGAGCTC CCAACGTAATCATGCTCCAT)
which, except for the added restriction sites (underlined), are the
same primers that J. Oscarsson used to clone rot in pWA163 [11].
The PCR-fragment was TOPO-cloned (Invitrogen), and after
confirming that the resulting plasmid contained an error-less rot-
gene, it was cloned into pRMC2 in the anti-sense orientation using
SacI and EcoRI. The plasmid was first introduced into RN4220,
purified from this strain using the Qiagen Plasmid Midi prep kit
and then introduced into SA564 by electroporation as described
by [31].
pLOJ132. A fragment containing the rpoB-promoter region,
the first part of the rpoB-leader, but leaving out the Shine-Dalgarno
and startcodon was PCR amplified using the primers Prpofwd (59-
AATGAATTCGTAAAGGAAAGTGATGC-39) and PrpoRevNy
(59-TCAGGTACCAAAAATTATGTGATCCGCTTTTAGC-
39), digested with EcoRI and KpnI and inserted into pUC19
generating pLOJ130. A fragment containing part of the rot-leader
[33] and the first 3 aa codons was PCR amplified using the
primers o-loj-rotmfwdny (59-GCGGTACCTTATGCATAAG-
TTAGCACATAC-39) and o-loj-rotmrev (59-GCGGA TCCT-
TTTTTCATGCTAAACATC-39), digested with KpnI and BamHI
and inserted into pLOJ130 generating pLOJ131. Subsequently, an
EcoRI—BamHI-fragment from pLOJ131containing the PrpoB-rot-
leader was gel purified (GFX) and ligated into pLUG520 where
the PrpoB-spa-fragment had been excised using the same enzymes.
This resulted in pLOJ132; PrpoB-rot-leader translationally fused to
lacZ in a pLUG520 derivative.
pLOJ133. A fragment containing the rpoB-promoter region,
the rpoB-leader, and the Shine-Dalgarno and startcodon was PCR
amplified using the primers Prpofwd and PrpoRev2 (59-GC-
GGATCCTGCCAAACAGATTCAC-39), digested with EcoRI
and BamHI and ligated into pLUG520 where the PrpoB-spa-
fragment had been removed using the same enzymes. This
resulted in pLOJ133; PrpoB translationally fused to lacZ in a
pLUG520 derivative.
The plasmids were introduced into S. aureus strain RN4220 by
electroporation and purified using the miniprep kit from Omega.
The plasmid isolation procedure was modified by incubating the
cell suspension in solution I containing 50 mg ml21 lysostaphin
(Sigma) for 1 h at 37uC. The purified plasmids were subsequently
introduced into other S. aureus strains by electroporation.
Transductions were performed as described by [34] using Q11.
Overexpression and purification of Rot and ClpX His-
tagged fusion proteins and generation of anti-Rot- and
anti-ClpX antibodies
A fragment containing the full-length rot gene was generated by
PCR using primers o-loj-rot-7 (59-GGATTTCCATATGAA-
AAAAGTAAATAACGACACTG-39) and o-loj-rot-10 (59-GGG-
AATTCTTACACAGCAATAATTCGGTTTAAACTATTTT-
GC-39), digested with NdeI and EcoRI and cloned in-frame with six
N-terminal histidine codons downstream of the IPTG-inducible
T7 promoter of pET28a+ (Novagen) resulting in plasmid
pLOJ104. DNA sequence analysis was performed to verify the
construction and the absence of mutations. However, we were
unable to recover error-less clones and for the purpose of antibody
production we chose to continue with a clone containing a
mutation leading to an Ala129RArg substitution.
A fragment containing the full-length clpX gene was generated
by PCR using primers ClpX100fwd (59-caccATGTTTAAATT-
CAATGAAGATGAAGAAAATTTG-39) and ClpX100rev (59-
TTA AGCTGATGTTTTACTATTATTAATTAAATTGCC-
39), TOPO-cloned into pET100D/TOPO (Invitrogen) in-frame
with six N-terminal histidine codons downstream of the IPTG-
inducible T7 promoter resulting in plasmid pET100clpX. DNA
sequence analysis was performed to verify the construction and the
absence of mutations. However, we were unable to recover error-
less clones and for the purpose of antibody production we chose to
continue with a clone containing a single amino substitution.
To induce synthesis of the His-tagged Rot and ClpX proteins in
E. coli, ER2566/pLOJ104 and ER2566/pET100clpX were grown
in 2xLB to an OD600 of 1.0 and then induced by adding IPTG to
a final concentration of 1.0 mM for 2 h. The overexpressed
proteins were purified on a Nickel NTA resin as described by the
manufacturer (Qiagen) and 200 mg of pure protein was used to
immunize a rabbit (antibodies were produced by CovalAB
Company) using standard procedures (Sambrook et al., 1989).
Overexpression and purification of Hfq protein and
generation of anti-Hfq-antibodies
For purification of Hfq, the intein system (Impact-CN; New
England Biolabs) was used. Protein purification was performed as
described previously [35]. Anti-Hfq-antibody was produced by
Charles River Laboratories by immunizing rabbits with purified
Hfq protein. The specificity of the antibody was tested by Western
blot analysis on purified Hfq protein and protein extracts.
Western blotting
S. aureus strains were grown in TSB as specified above.
Exponential cells were harvested at OD600 = 1.0 (+/20.1), and
post-exponential samples at OD600 = 2.0 (+/20.1), or OD600 = 3.0
(+/20.1), and used for isolation of intracellular proteins. One ml
aliquots were harvested and kept at 280uC until all samples were
collected. The cell pellets were thawed on ice, resuspended in
50 mM TrisHCl, Ph = 7.4 to a calculated OD600 of 10.0. PMSF,
Dnase, Rnase and lysostaphin were added to the samples, and they
were incubated at room-temperature for 15 min. Cellular debris
was removed by centrifugation and the protein concentration of
each sample was measured using the Bradford dye-binding
procedure from Bio-Rad. For immunoblotting a total of 5 mg (or
10 mg for Hfq-immunoblotting) of each sample was loaded on
NuPAGEH 4–12% Bis-Tris gels (Invitrogen) using MOPS-Buffer
(Invitrogen). The proteins were blotted onto a polyvinylidene
difluoride membrane using the XCell II blotting module
(Invitrogen). The membranes were pre-blocked with IgG. The
Rot and ClpX proteins were probed using Rabbit-anti-Rot-
antibody or Rabbit-anti-ClpX-antibody at a 1:2000 dilution.
Protein A was probed using monoclonal Mouse-anti-Protein-A-
antibodies (Sigma) at a 1:10000 dilution. The Hfq protein was
probed using anti-Hfq antibodies at a 1:2500 dilution. Bound
antibody was detected with the WesternBreeze Chemiluminescent
Anti-Rabbit kit or Anti-mouse kit (Invitrogen). All Western blots
were repeated at least three times with similar results.
RNA extraction and Northern blot analysis
Cells were grown in TSB at 37uC with shaking to the indicated
OD600. 1 ml aliquots were harvested and immediately frozen and
ClpX Stimulates Translation
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stored at -80uC. Cells were lysed mechanically using the FastPrep
system (Bio101; Q-biogene), and RNA was isolated using the
RNeasy mini kit (QIAGEN, Valencia, Calif.) according to the
manufacturer’s instructions. Total RNA was quantified by
spectrophotometric analysis (l= 260 nm), and 5 mg of RNA of
each preparation was loaded onto a 1% agarose gel and separated
in 10 mM sodium phosphate buffer as described previously [20].
RNA was transferred to a positively charged nylon membrane
(Boehringer Mannheim) by capillary blotting as described by
Sambrook et al. Hybridization was performed according to [20]
using gene-specific probes that had been labeled with [32P]dCTP
using the Ready-to-Go DNA-labeling beads from Amersham
Biosciences. Internal fragments of the rot gene (amplified with the
primers o-loj-rot-7 and o-loj-rot-10), spa (amplified with the
primers described in [20]) or the rnalll gene (amplified with the
primers 5’- GATCACAGAGATGTTATGG + 5’-CATAG-
CACTGAGTCCAAGG) were used as template in the labeling
reactions. All steps were repeated in three independent experi-
ments giving similar results.
Measurements of b-galactosidase activity
Cells were grown in TSB as described above to the indicated
OD600. 1 ml aliquots were harvested and immediately frozen and
stored at 220uC. Cell pellets were resuspended in 300 ml 0.9%
NaCl containing 5 mg/ml lysostaphin and incubated at 37uC for
15 min until the samples became clear indicating lysis was
complete. Cellular debris was removed by centrifugation and the
samples were transferred to fresh tubes. The protein concentration
of each sample was measured using the Bradford dye-binding
procedure from Bio-Rad. Expression of b-galactosidase was
quantified by adding 400 ml Z-buffer contaning 1 mg/ml ONPG
to 100 ml of each sample as described previously [36]. Samples
were incubated at 37uC until the solution had become yellow or
not longer than 180 min. The reaction was stopped by adding
500 ml 1 M NaCO3 and b-galactosidase activity was measured at
OD420 and the specific activity (1 unit = 1 nmole o-nitrophenol
produced per min per mg protein) was calculated. All steps were
repeated in three independent experiments giving similar results.
Statistical analysis. All significant values were determined
using the 2 sample t-test with unequal variances. Error bars
represent standard deviations.
Results
Cells lacking ClpX contain reduced levels of the Rot
transcriptional regulator
Similar to the transcriptional regulator Rot, ClpX is required
for transcription of the spa gene, encoding Protein A [20,21].
Based on this observation we proposed that the chaperone activity
of ClpX is required either to activate Rot, or, to control expression
of Rot [20]. To estimate the level of Rot protein in the clpX mutant
cells, we prepared polyclonal antibodies against Rot. The Rot
antibodies were used to determine the relative amount of Rot
protein in wild-type cells and in cells carrying deletions in clpX,
clpP, or agr. As translation of the rot mRNA is inhibited by RNAIII
[17], the Rot level was assayed both in exponential growth phase
(prior to induction of RNAIII) and in post-exponential growth
phase (RNAIII induced) (Fig. 2). The anti-Rot antibodies
recognized a protein of the expected 16 kDa that was absent in
protein extracts derived from the rot mutant (Fig. 2A). In wild-type
cells the Rot protein was most abundant during exponential
growth phase (Fig. 2A), which is consistent with the inhibitory role
of RNAIII on rot translation [17,18]. In post-exponential cells the
Rot level was gradually reduced, reaching 75% and 50% of the
exponential level at OD600 = 2.0 and 3.0, respectively. In
accordance with the proposed model, the down regulation of
Rot was clearly dependent on agr. Interestingly, cells lacking ClpX
contained 2–3 fold less Rot protein than wild type-cells at all
assayed time-points (Fig. 2A). As restoration of the chromosomal
clpX locus, resulted in wild-type expression of both Rot and Protein
A we conclude that ClpX indeed has a stimulatory effect on Rot
synthesis (Fig. 2B and data not shown).
Figure 2. Expression of Rot is decreased in cells lacking ClpX. Proteins from wild-type, and clpX, rot, or agr mutant cells, (A), wt, clpX mutant
cells and clpX complemented clpX mutant cells (DclpX+clpX) (B), and wild-type and clpP mutant cells (C) were extracted from exponential (OD600 = 1.0
(+/20.1)) or post-exponential cells (OD600 = 2.0 (+/20.1) and OD600 = 3.0 (+/20.1) as indicated. In each blot extracted proteins were separated by SDS-
PAGE, blotted onto a PVDF membrane and probed with Rot antibody (A, B, central panel and, C) and ClpX antibody (B, upper panel). To visualize
equal loading, signals detected from non-specific binding of the Rot antibody to an unknown cellular protein are shown. The Rot protein levels in (A)
and (C) were quantified relative to the wild-type Rot level in exponential cells (100%) using NIH imageJ 1.40. The ClpX protein, Rot protein and
loading control protein levels in (B) were quantified relative to the wt level (100%) using Gene-snap from Perkin Elmer. The Western blots were
repeated in at least 4 independent experiments giving similar results.
doi:10.1371/journal.pone.0012752.g002
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The post-exponential down regulation of Rot was still observed
in the clpX mutant, indicating that the effect of ClpX and RNAIII
on Rot expression is mediated by different pathways. Moreover,
cells lacking clpP contained wild-type levels of Rot protein at all
assayed time-points (Fig. 2C), signifying that ClpX enhances Rot
expression independently of ClpP.
Expression of spa is activated above a threshold level of
Rot
After confirming that ClpX is required for full expression of
Rot, we examined whether the 2–3 fold reduction of the Rot level
can explain the dramatically reduced Protein A level of the clpX
mutant [20]. To control the Rot-level, we employed a rot mutant
that harbours a plasmid carrying the rot gene transcribed from a
xylose inducible promoter [11]. Protein samples were derived from
exponential cultures grown with varying amounts of xylose, and
were used for Western blot detection of Rot and Protein A. As
seen in Fig. 3, upper panel, Rot expression increased with
increasing concentrations of xylose, and with 4% added xylose the
Rot level approached the wild-type level. The experiment clearly
demonstrated that Protein A synthesis was dependent on the Rot
levels (Fig. 3, central panel). Specifically, Protein A expression
remained low until the level of Rot protein constituted
approximately 75% of the wild-type level. As Rot controls Protein
A synthesis at the level of transcription, this finding indicates that a
threshold concentration of Rot must be exceeded to obtain
induction of spa transcription. Importantly, in the clpX mutant, the
Rot level was below this threshold level (the level was comparable
to the Rot level in cells grown in the presence of 0.5–1% xylose).
Hence, this experiment confirms that the reduced level of Rot in
the clpX mutant can explain the severely reduced spa transcription
in this strain [20]. Additionally, our results suggest that Protein A
expression is regulated by a threshold mechanism.
The essential roles of ClpX and Rot in Protein A
expression are conserved in a clinical strain
The increasing focus on virulence gene regulation in clinical
strains has emphasized that regulatory models established in
laboratory strains may not be representative of the regulatory
mechanisms observed in clinical isolates [37–39]. To assess if the
role of ClpX in Rot and Protein A synthesis is conserved in clinical
isolates, we made the 651 bp in-fame deletion of the clpX gene in
the low-passage isolate SA564 derived from a patient with toxic
shock syndrome [37]. Expression of Protein A and Rot in the
SA564DclpX strain and SA564 wild type strain was compared
using Western blot analysis (Fig. 4A). Strikingly, the stimulatory
role of ClpX on Rot/ProteinA synthesis appears even more
pronounced in the SA564 background, as deletion of clpX in
SA564 substantially reduced (approximately 6 fold) the cellular
level of Rot, and concomitantly decreased spa transcription and
Protein A synthesis to less than 5% of the wild-type level (Fig. 4A).
Upon complementation of the clpX locus, Protein A and the Rot
level were returned to wild-type levels (Fig. 4B). We conclude, that
the positive roles of ClpX on Rot and Protein A synthesis are
conserved in a low-passage clinical strain, suggesting that the
underlying mechanism is conserved among S. aureus strains.
The SA564 strain expresses considerably more Protein A than
8325-4, and we therefore examined if Protein A expression is
dependent on a threshold-level of Rot, as was observed for 8325-4
(Fig. 3). To reduce the cellular Rot level in SA564, the rot gene was
cloned in the anti-sense orientation under control of the tetO
promoter in the expression vector pRMC2 (see Materials and
Methods for details; 32). As can be seen in Fig. 5, we could achieve
a minor reduction (2 fold at the highest concentration of
anhydrotetracycline) in the cellular Rot concentration by inducing
transcription of the rot anti-sense mRNA. Interestingly, this modest
reduction of Rot reduced expression of Protein A as much as 10
fold. This finding supports that below a threshold level of Rot,
Protein A synthesis is greatly reduced.
rot transcription is slightly reduced in clpX and clpP
mutant cells
We next attempted to pin-point the level at which ClpX
mediates its affect on Rot synthesis. We first examined if ClpX
controls Rot synthesis at the level of transcription. To this end,
Northern blot analysis was performed to determine the level of rot
transcript in exponential and post-exponential wild-type, clpP, and
clpX mutant cells (Fig. 6). The Northern blot revealed that both
clpX and clpP mutant cells contained rot-transcript levels that were
slightly reduced compared to wild-type levels. As described above,
the Rot protein level in the clpP mutant strain was comparable to
the wild-type level, suggesting that the reduced rot transcription in
clpX and clpP mutant strains is not reflected at the protein level.
The Northern blot also revealed that in all strains transcription of
rot increased in the post-exponential growth phase, as also reported
by others [18]. The post-exponential induction of rot transcription
occurs concomitantly with the down-regulation of Rot at the
protein level emphasizing the significance of posttranscriptional
regulation in Rot expression. From this experiment, we conclude
that ClpX controls Rot synthesis mainly at the post-transcriptional
level.
ClpX does not control Rot expression by stimulating
transcription of RNAIII
Next, we addressed if ClpX controls Rot expression by
enhancing expression of RNAIII that is an inhibitor of Rot
translation [17]. To this notion, the level of RNAIII in wild-type,
Figure 3. Rot performs threshold regulation of Protein A
expression. The effect of the Rot concentration on Protein expression
A was assayed by growing a rot-mutant expressing rot from a xylose
inducible promotor in five parallel cultures supplemented with
increasing amounts of xylose. Samples were collected at OD600 = 1.0
and total protein was extracted, equal amounts of protein in each lane
was separated by SDS-PAGE, blotted onto a PVDF membrane, and
probed to Rot polyclonal antibody (upper panel) and Protein A
monoclonal antibody (lower panel). For comparisons, the Rot- and
Protein A levels were determined in wild-type cells and in cells lacking
either clpX or spa. To visualize equal loading, signals detected from non-
specific binding of the Rot antibody to an unknown cellular protein are
shown in the bottom panel. The Rot protein, Protein A, and loading
control protein levels were quantified relative to the respective wild-
type level in exponential cells (100%) using NIH imageJ 1.40. Each
experiment was performed three times with similar results.
doi:10.1371/journal.pone.0012752.g003
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agr, and clpX mutant cells in exponential and post-exponential
growth phase was determined by Northern blot analysis (Fig. 7).
The experiment demonstrated that the RNAIII level in the clpX
mutant does not deviate from the wild-type levels. Hence, we ruled
out that the reduced Rot level in the clpX mutant is accomplished
through an increase in RNAIII synthesis.
ClpX stimulates translation of rot mRNA
To investigate directly whether ClpX regulates Rot translation,
a translational fusion between the 59-rot-leader and lacZ was
constructed as depicted in Fig. 8A. This construct encompasses the
RNAIII interacting region, the ribosome binding site, and the first
three amino acid codons of the rot leader translationally fused to
lacZ [17,33]. Transcription of the fusion is driven by the
constitutive promoter PrpoB. The plasmid harbouring the rot-
translational fusion was introduced into wild-type, and agr, clpX,
clpP, and agr;clpX mutant strains, and b-galactosidase activity was
assayed in samples derived from post-exponential cultures (Fig. 8B).
The assay revealed that b-galactosidase activity was almost five
fold higher in the agr mutant than in the wild-type (Fig. 8B). This
suppressive effect of RNAIII on rot-translation is in the same range
as observed by others and, thus, validates the constructs [17].
While samples derived from clpP mutant cells expressed wild-type
levels of b-galactosidase (data not shown), b-galactosidase activity
was reduced approximately two fold compared to wild-type in
clpX mutant cells. This two-fold difference was statistically
significant (wild-type different from clpX; P-value = 0.008), indi-
cating that ClpX indeed has a positive effect on translation of rot.
Interestingly, b-galactosidase activity in the agr, clpX double
mutant was substantially reduced compared to the activity
measured in the agr single mutant strain. This suggests that even
though the inhibitory effect of RNAIII is relieved by a deletion of
the agr locus, translation of Rot still depends on ClpX. Taken
Figure 4. Protein A and Rot expression is substantially reduced in a clinical isolate carrying the clpX deletion. (A) Rot antibody and,
Protein A antibody, were used to estimate the Rot, and Protein A levels in SA564 and the clpX deletion mutant at the indicated time-points. (B) ClpX
antibody, Rot antibody, and Protein A antibody were used to estimate the ClpX, Rot, and Protein A levels in post-exponential cells (OD600 = 2.0
(+/20.1)) of SA564, the clpX deletion mutant derived from it, and the clpX complemented clpX mutant (DclpX+clpX). To visualize equal loading the
signals detected from non-specific binding of the Rot antibody to an unknown cellular protein is shown. Rot protein and Protein A levels were
quantified relative to the wild-type Rot/Protein A level in exponential cells (100%) using Gene Snap from Perkin Elmer. (C) At the same time-points
total RNA was extracted and the level of spa transcript in SA564 wild-type and clpX mutant cells was assessed by Northern blot analysis (third panel).
The spa signals were quantified relative to the wild-type SA564 spa signal in exponential cells ( = 100%) using the Cyclone Plus Phosphor imager from
PerkinElmer. To visualize equal loading, a picture of the ethidium stained agarose gel is shown in the bottom panel. Note that the middle 5 lanes
containing samples not relevant to this study have been removed from both the Northern blot and the agarose gel.
doi:10.1371/journal.pone.0012752.g004
Figure 5. Protein A expression is dependent on the Rot level in
SA564. To reduce the level of Rot in SA564, anti-sense rot mRNA was
expressed from the tetO promoter in pRMC2 in the presence of
increasing concentrations of the inducer anhydrotetracyclin. Anhydro-
tetracyclin was added at OD600 = 0.4 and proteins were extracted from
samples derived at OD600 = 2.0. Western blotting was performed with
Rot antibody (upper panel) and protein A mono-clonal antibody
(second panel). To visualize equal loading the signals detected from
non-specific binding of the Rot antibody to an unknown cellular protein
is shown. All protein levels were quantified relatively to the
corresponding signal obtained in the un-induced culture (100%) using
Gene Snap from Perkin Elmer.
doi:10.1371/journal.pone.0012752.g005
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together; these results specify that ClpX stimulates rot translation,
and that the role of ClpX in rot translation is not linked to the
RNAIII mediated inhibition of rot translation.
ClpX stimulates translation of spa mRNA but not of rpoB
mRNA
Huntzinger et al. showed that translation of spa (Protein A),
similar to translation of Rot, is inhibited by RNAIII [12]. To
examine if ClpX has a role in translation of Protein A, the plasmid,
pLUG520, carrying the PrpoB-spa-lacZ translational fusion used by
Huntzinger et al. [12] was introduced into wild-type and mutant
strains. This construct encompasses the constitutive rpoB promoter
and the first 63 nucleotides of the spa mRNA (including the sites
for RNAIII interaction) fused in frame with lacZ deleted of its
ribosomal binding site, and thus specifically measures the
translational activity of the spa-leader. In samples derived from
post-exponential cultures, b-galactosidase activity was approxi-
mately 1.5 fold higher in the agr background than in the wild-type
background, in accordance with previous results obtained by
Huntzinger et al. [12] (Fig. 8C). Importantly, the absence of ClpX
reduced b-galactosidase activity expressed from the spa-lacZ
translational fusion approximately 5 fold, both in wild-type and
in cells devoid of agr/RNAIII. We conclude that translation of spa
mRNA, similar to translation of rot mRNA, is positively affected by
ClpX and that the positive effect of ClpX on spa and rot translation
occurs independently of RNAIII.
To investigate if ClpX also contributes to translation of mRNAs
not interacting with RNAIII, we examined expression of the
house-keeping gene rpoB in the clpX mutant by using a
translational fusion between the rpoB promoter and lacZ
(pLOJ133). With this plasmid, b-galactosidase activity was similar
in samples derived from all strains demonstrating that neither
RNAIII nor ClpX regulates expression of RpoB (Fig. 8D).
Discussion
Protein A is an abundant surface protein that by its ability to
bind the Fc fragment of immunoglobulins from mammalian
species is believed to be important for immune evasion of S. aureus
[5]. Previously, we have shown that ClpX (but not ClpP), similar
to the transcriptional regulator Rot, is essential for transcription of
the spa gene encoding Protein A, and therefore we hypothesized
that the chaperone activity of ClpX is required for either synthesis
or activity of Rot [20]. In the present study we confirm that ClpX
is indeed required for full expression of Rot, as cells devoid of
ClpX contain approximately 2–3 fold less Rot protein than wild-
type cells. This finding raised the question whether the relatively
modest 2–3 fold reduction in the cellular Rot level is sufficient to
abolish spa transcription. We confirmed this by varying Rot
expression from an inducible promoter and demonstrated that a 2
fold reduction in Rot expression causes a dramatic 90% reduction
in Protein A expression in both 8325-4 and the low-passage
clinical isolate SA564 [40]. This finding emphasizes that major
changes in Protein A expression may be achieved by small
reductions in the Rot level and suggests that a threshold level of
Rot is needed for synthesis of protein A.
Rot stimulates Protein A transcription both directly, by binding
to the spa promoter, and in-directly by enhancing transcription of
Figure 6. Expression of rot transcript is slightly decreased in clpX, and clpP mutant cells. The level of rot transcript was estimated by
Northern blot analysis: Total RNA was extracted from wild-type and mutants lacking either clpP or clpX and separated on an agarose gel. Equal
amounts of RNA were loaded in each lane. The RNA was blotted onto a nitrocellulose membrane and probed with a rot specific probe. Upper panel
shows the resulting Northern blot, while ethidium stained agarose gel is shown below. The result is representative of 3 independent experiments.
doi:10.1371/journal.pone.0012752.g006
Figure 7. Expression of RNAIII is not altered in the clpXmutant.
Cells of the wild-type and the agr, and clpX mutants were grown in TSB
and at the indicated optical densities total RNA was extracted and
separated on an agarose gel. RNA was blotted onto a nitrocellulose
membrane and probed with an RNAIII specific probe. Below the blot is a
picture of the ethidium stained agarose gel. The blot presented is
representative of three independent experiments.
doi:10.1371/journal.pone.0012752.g007
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Figure 8. Translation of Rot and Protein A is decreased in the absence of ClpX. (A) Schematic drawing of the lacZ translational fusion
points in pLOJ132 and pLOJ133. pLOJ132 is a PrpoB-rot-lacZ translational fusion. Transcription is driven from the constitutive PrpoB promoter. The rot-
leader encompassing the RNAIIII interacting region from +162 to +250 (numbered with respect to the transcriptional start site) is translationally fused
to the lacZ gene. pLOJ133 is a PrpoB-lacZ translational fusion. (B) b-Galactosidase activity measured in post-exponential (OD600 = 2.0) wild-type- and,
clpX, agr, agr;clpX mutant strains harbouring pLOJ133. The specific activities are presented as a percentage of the wild-type activity (100%). P-values
were calculated using the two-sample t-test with unequal variances: wild-type different than clpX: P-value= 0.008; agr different than agr;clpX: P-
value = 0.0004. The statistical calculations were based on five independent experiments. (C) Protein A translation was measured as b-Galactosidase
activity expressed from pLUG520 in wild-type- and clpX, agr, and agr;clpX mutant cells in the post-exponential growth phase (OD600 = 2.0). Specific
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sarS, encoding another positive activator of spa transcription
[11,13,41]. Interestingly, transcription from the spa promoter was
suggested to be regulated by negative (SarA) and positive
regulators (SarS and Rot) competing for overlapping operator
sites [13]. Therefore we propose that the threshold level of Rot
(and SarS) is required to relieve the repression imposed by SarA,
and that the ClpX dependent expression of Rot is required to
exceed this threshold level. It is tempting to speculate that
additional genes of the Rot regulon are subject to a similar
regulatory mechanism.
As deletion of clpX severely decreased the Rot level (6 fold
compared to the max 3-fold in 8325-4), and accordingly abolished
expression of Protein A in the low-passage isolate SA564, we
propose that the mechanism by which ClpX controls the Rot and
Protein A level is conserved among clinical S. aureus isolates.
Attempts to pin-point the level at which ClpX mediates its effect
on Rot synthesis demonstrated that ClpX stimulates expression of
Rot both at the level of transcription and translation (Fig. 6 and 8).
Based on the finding that transcription of rot was decreased
similarly by the absence of either ClpX or ClpP, we propose that
ClpX controls rot transcription as part of the ClpXP proteolytic
complex. Notably, the clpP mutant strain contained wild-type
levels of Rot suggesting that the reduction in rot transcription
observed in clpX and clpP mutant strains is not reflected in the
cellular Rot level, and hence that the ClpP independent effect of
ClpX in controlling Rot synthesis is achieved mainly at the post-
transcriptional level. Accordingly, we were able to show that ClpX
does indeed stimulate translation of the rot mRNA, and that ClpX
additionally enhances translation of the spa mRNA. Initially this
observation prompted us to suspect that ClpX modulates the
interaction between RNAIII and its target mRNA’s. This
interaction involves base pairings between RNAIII and secondary
hair-pin structures in the target mRNA by which dual loop-loop
complexes are formed. These interactions block ribosomal access
to the Shine-Dalgarno of the respective messengers, thereby
inhibiting translation [17,18]. However, as we observed a
substantial ClpX dependent stimulation of spa and rot translation
in cells lacking RNAIII, we conclude that ClpX stimulates
translation independently of RNAIII.
Secondary structure determinations of the spa- and rot-mRNAs
reveal that the translational signals are partially obscured in the
stem-loop structures, also when not bound to RNAIII [12,17].
Consequently, it is possible that the structures of the spa and rot
transcripts required for interactions with RNAIII could hamper
interactions with the ribosomes even in the absence of RNAIII.
Hence, one way ClpX may promote translation of the rot and spa
mRNAs is by, directly or indirectly, unfolding the stem-loop
structures to facilitate interaction of these mRNAs with the
translational apparatus.
In E. coli, the abundant RNA chaperone Hfq has a central role
in translational stimulation of specific mRNAs [42]. Hfq is the only
RNA chaperone yet identified in S. aureus. Accordingly, Hfq could
be a candidate through which ClpX mediates its function in
translational stimulation. However, recently the biological signif-
icance of Hfq in S. aureus was questioned by the lack of phenotypes
of an hfq mutant and by the lack of detection of the hfq mRNA
[18,40]. Consistent with this finding we were not able to detect
Hfq in our strains when performing Western blot analysis using
anti-Hfq polyclonal antibodies (raised against Hfq purified from S.
aureus, see Materials and Methods, Supplemental Fig. S1).
Furthermore, as both expression of Protein A and Rot did not
change in strains lacking Hfq [40], it seems unlikely that the
stimulatory effect of ClpX on translation of the rot- and spa
transcripts is mediated through Hfq. Rather, S. aureus may harbour
a yet unidentified RNA chaperone that is subject to regulation by
ClpX.
An intriguing alternative possibility is that ClpX could affect
translation through direct binding to specific mRNAs. The ClpX
family of proteins contains a C4 zinc-binding domain in the N-
terminal region and this type of domain has been implicated in
nucleic acid binding in both eukaryotic and prokaryotic organisms
[43,44]. In addition, a eukaryotic relative of ClpX, the HSP101
heat shock protein of plants specifically binds to and stimulates
translation of the A-rich 59 un-translated leader of the tobacco
mosaic virus [45]. Inspection of the three-dimensional structure of
ClpX, furthermore, reveals a striking resemblance to the RNA
binding protein Hfq as both proteins form homo-hexameric ring-
structures with similar sizes of the central pores. Further
experiments are underway to determine the mechanisms of ClpX
mediated translational stimulation.
In conclusion, we have shown that ClpX has a dual role in
stimulating Protein A synthesis, as ClpX enhances both transcrip-
tion (through enhancing synthesis of Rot), and translation of spa.
Our findings emphasize that ClpX through its role in fine-tuning
the level of the central regulator Rot holds an important role in
controlling global expression of virulence factors in S. aureus.
Supporting Information
Figure S1 Hfq could not be detected in Western blot analysis.
Cells were harvested in early stationary phase or late stationary
phase. Cells were lysed as described in materials and methods and
total protein extract were separated on an SDS-gel. 10 mg protein
was loaded (0.5 mg purified S. aureus Hfq protein).and samples
were heated to 95uC for 20 min prior to loading. For comparison
of protein sizes, the PageRulerTM Plus Prestained Protein Ladder
(Fermentas) was included (not shown). The Hfq antibody
specifically recognizes the monomeric and multimeric species of
the purified Hfq protein, whereas no bands at corresponding sizes
were observed in any of the cellular protein samples tested.
Found at: doi:10.1371/journal.pone.0012752.s001 (2.49 MB TIF)
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